Skip to content

Dr. COVELIERS

Active
Private limited companyfounded 2020active for 6 yearsRue des Eglantiers 7, 4053 Chaudfontaine, BelgiumKBO/BCE: BE 0755.660.286

From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. COVELIERS has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,500 and a net result of €66,480. Equity has been growing by about 47% per year since 2021. Its solvency ranks better than 8% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Official details

KBO
Status
Active since 05-10-2020 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.308.714.519 4053 Chaudfontaine, since 05-10-2020
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • COVELIERS AmauryDirector · since 05-10-2020

Financial position

81 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Annual accounts 2025
Gross margin
€90,166
▼ 30.1%
Turnover
≈ €200,000
estimated
Profit
€66,480
▼ 30.7%
Equity
€2,500
▼ 99.2%
Total assets
€77,347
▼ 76.8%
Filed on 26-03-2026, 127 days before the deadlinePDF
Score breakdownraises risk1 change of registered office in 24 monthsEquity €2,500 (3.2% of total assets)lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 26-03-2026)Show the evidence

Checked score

Score 2025
81 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 23% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Weak
Solvency 28-72
equity 3.2% of total assets
Liquidity 11-42
short-term debt 96.8% · cash 8.7%
Profitability 100=
return on assets 85.9%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: 0.1%▲ +0.1 percentage points vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.3 percentage points vs 06-2026highest value 08-2026: 0.4%● unchanged vs 07-2026highest value 09-2026: 0.4%● unchanged vs 08-2026 10-2026: 0.4%● unchanged vs 09-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 9% of them on solvency, 1% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed on 26-03-2026)
NBB · annual accounts
raises risk · Equity €2,500 (3.2% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 8%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-03-2026, 127 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
127 days early
2024
27 days early
2023
35 days early
2022
30 days late
2021
29 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 26 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 July (4 of the last 5 accounts filed within 57 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €326,695 to €2,500 ▼ 99.2% View
  • Caution: Less equity than 93% of companies in human healthsector median €124,628 · 20,680 companies €2,500 View
  • Positive: 5 profitable years in a rowprofit 2025: €66,480 5 years View

Comparable companies

These companies have the same main activity as Dr. COVELIERS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €70,800 and €85,400, founded between 2020 and 2021.

CompanyTotal assetsGross margin
Dr. COVELIERS Chaudfontaine€77,347€90,166
Dokter Elise Raymaekers Bierbeek€82,478€92,744
DR. EVELYN WINNE Jabbeke€70,836€92,570
Dokter Tans Céline Zonhoven€73,455€96,277
SDG Medic Brussel€85,383€84,548
Dr. Jolien Dirckx Leuven€80,434€99,857
Huisarts Corneel Verburgh Huldenberg€80,559€98,931
Full comparison

Documents

Annual accounts at the NBB

All 5 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. COVELIERS

What is the company number of Dr. COVELIERS?
The company number of Dr. COVELIERS is 0755.660.286. The VAT number is the same number with BE in front: BE 0755.660.286.
Where is Dr. COVELIERS based?
The registered office is at Rue des Eglantiers 7, 4053 Chaudfontaine.Company details
What does Dr. COVELIERS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. COVELIERS?
The legal form of Dr. COVELIERS is Private limited company (BV).
When was Dr. COVELIERS founded?
Dr. COVELIERS was founded on 05-10-2020.
Is Dr. COVELIERS still active?
Yes, Dr. COVELIERS is an active enterprise in the KBO register.
What is the turnover of Dr. COVELIERS?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €90,166 and 32 comparable companies (NACE 862). It probably lies between €160,000 and €260,000.Financials
Is Dr. COVELIERS profitable?
In financial year 2025, Dr. COVELIERS made a profit of €66,480.
Where can I find the annual accounts of Dr. COVELIERS?
Dr. COVELIERS filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. COVELIERS due?
Dr. COVELIERS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.